| 1. Which is the most important criteria in accepting
a product derived from biotechnology (e.g. food, pharmaceuticals)?
Safety - 27 votes (49 %)
Ethics
and religions - 12 votes (21%)
Consumer
benefits - 8 votes (14%)
Environmental
impact - 4 votes (7%)
Regulation
- 3 votes (5%)
Price
- 2 votes (4%)
Total votes - 56 |
 |
|
| 2.
Who would you trust the most in making a decision on biotechnology products
and services?
Scientist - 23 votes (44%)
International
agencies (e.g. FAO, WHO) - 16 votes (30%)
Industries - 6 votes (11%)
Government
agencies - 5 votes (9%)
NGO's
- 3 votes (6%)
Agencies
in developed countries (e.g. USDA, USFDA) - 0 votes (0%)
Total votes - 53 |
 |
4.
Do you think the various stakeholders involved in biotechnology (policy
makers, scientists, industries, religious authorities, media) are communicating
enough on biotechnology?
Yes - 4 votes (8%)
No - 35 votes (73%)
Could
be improved - 9 votes (19%)
Don't
know - 0 votes, (0%)
Total votes - 48
|
 |
|
Perception on biotechnology by the public has been known to be varied
at times, and a recent poll by MABIC has shown such tendencies of our
readers in general. When queried on the central criteria they would derive
in accepting biotech products, respondents believed that safety was most
important, garnering 48% of votes, in comparison to the 27% of ethics
and religion, this is followed by consumer benefits, 14%, environmental
impact, 7%, regulation, 5% and price, 4%.
On the other
hand, when choosing their most trusted source of information in deciding
the use of biotech products, readers were generally split over scientists
(43%) and International Agencies (30%), followed by industries (11%),
Government agencies (9%) and NGOs (6%).
In terms of
the manner the government is promoting biotech, readers generally believed
that it is much one-sided, as 20 who voted believed that it could be improved
and 24 polled believed that the government was not promoting it in a balanced
manner. This is contrasted by the singular voter who believed that the
government was balanced in its promotion of biotech.
As for the
amount of information out there, 52% of voter believed that there was
not enough to make an informed decision. While 43% believed that it could
be improved. This is no surprise as readers believed in general that biotechnology
stakeholders are not communicating enough biotechnology (73%) compared
to 8% who believed otherwise, and 19% who believed that such communication
could be improved.
|